U-Blot® Research Grade PerakizumabCat. No. WA3352Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade PerakizumabCat. No. WA3352U-Blot® Research Grade PepinemabCat. No. WA3351Request quote
Size: 50ug/100ug
U-Blot® Research Grade PenpulimabCat. No. WA3350Request quote
Size: 50ug/100ug
U-Blot® Research Grade PemtumomabCat. No. WA3349Request quote
Size: 50ug/100ug
U-Blot® Research Grade pemivibartCat. No. WA3348Request quote
Size: 50ug/100ug
U-Blot® Research Grade PembrolizumabCat. No. WA3347Request quote
Size: 50ug/100ug
U-Blot® Research Grade peluntamigCat. No. WA3346Request quote
Size: 50ug/100ug
U-Blot® Research Grade PelgifatamabCat. No. WA3345Request quote
Size: 50ug/100ug
U-Blot® Research Grade PegrizeprumentCat. No. WA3344Request quote
Size: 50ug/100ug
U-Blot® Research Grade PegfilgrastimCat. No. WA3343Request quote
Size: 50ug/100ug
U-Blot® Research Grade PavurutamabCat. No. WA3342Request quote
Size: 50ug/100ug
U-Blot® Research Grade PavunalimabCat. No. WA3341Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598